Drug screening technology changes affect the global pharmaceutical market

Over the years, the global pharmaceutical companyscreening by Shi Yong Huo cell basis as a drug
focused on research and development on the fasterdiscovery to address this issue, therefore, the
and better develop the technology for clinical drugstechnology of another name is cell-based screening.
are very interested, and whom continue to workHigh-content drug screening defining characteristic is
very hard. Unfortunately, the discovery process wasnot observed drug candidates at a particular time
considered to be more reasonable and moreinstant on the subject of the role of a single target,
effective technology is not able to achieve its originalbut the use of a single instrument can work in a
vision. The fact is, despite the annual increase in thespace and time, number of cells within the tracking
cost of drug development, but the real into theprocess. The process involves a protein changes,
market without a commensurate number of newsuch as G-protein coupled receptor (GPCR) signal
products known for. This makes a number oftransduction, kinase-mediated signal transduction and
pharmaceutical companies have to rethink the way inion channel signal transduction. For example, GPCR
what to filter the drug, while considering whether toactivation can stimulate them into the cell. As
intervene directly to the development of the wholementioned earlier, this process is visible, thus providing
process.a specific objective to measure the efficiency of
 drug candidates.
High-throughput screening of Solomon 
 Cell electrolysis spectrum rivalry
Of the last century until the mid-90s, drug discovery 
is mainly through high-throughput screening (HTS). BeAlthough the original high-content drug screening
regarded as the original high-throughput screening ofidentified by the fluorescence determination, but
various heavy pharmacological activity in vitro and inother technologies such as cell electrolysis measured
vivo experiments a reasonable substitute, which isspectrum appears, for some processes provided a
heavily dependent on liquid handling robotic devices,better choice. It does not require agents or other
automated test equipment and computer control totypes of fluorescent markers for cell marking, and
study the new interest in biological target moleculescan also detect a number of cell signaling channel. At
and between interaction. And high-throughputpresent, this technology is relatively low flux limit for
screening is used to match the so-called combinatorialthe occasion, but the equipment manufacturers to
chemistry.increase throughput. In fact, the high content drug
 screening can also be used for nucleic acid-based
Combinatorial chemistry method excludes the studyprocesses, such as DNA transcription or RNA
of individual compounds, the traditional method, andinterference, as well as cellular processes such as
replaced the same time of hundreds or evenapoptosis, DNA damage repair or cell division occurs.
thousands of laboratory synthesized and stored in aObviously, these cases require different method. For
large database of compounds. Combinatorialexample, can be assayed for DNA degradation
chemistry methods De Chu Xian, gave birth to theassessment of apoptosis.
birth of new companies, these companies only 
mission is to create a combinatorial library, and thenHigh content drug screening is facing a major
transferred to the Drug Discovery, Gong interest ofproblem, because it is a kind of image-based
these companies target Jinxingshaixuan. Therefore, iftechnology, it can produce large amounts of data. For
there is no high-throughput screening technology, canexample, a single experiment can generate up to
not be such a huge number of compounds screened,10TB [trillion bytes; 1TB = 1000GB] data. Currently,
the application of high throughput screening processvendors are developing to deal with PB level (1PB =
to further promote the development of other1000TB) quantitative data equipment, all these data
aspects of progress.must be processed and stored, Xianran this Yaoqiu
 high content of drug screening have vast computing
It is worth mentioning that the completion of humanpower. Of course there are many other challenges,
genome projects, technological advances, such assuch as the need to develop new methods to
more compact (from the original 96-well plates,measure a particular cell type of interest (such as
grown to 384,1536 and even 456 well plates), butimmune system cells) in the process.
also help maintain the HTS technology as the main 
driving force for drug discovery . Other technologicalNevertheless, the advantages of high content drug
advances (including the new sense of technology)screening seems better than its shortcomings. The
such as quantitative protein drug candidates, whenmost significant advantage is that, compared with the
combined with changes in the differential scanningtraditional determination, it was more useful
calorimetry or light scattering measurements.information. High content screening data, the
 composition of space and time means that it studies
However, looking for new active molecules, thethan the traditional one-dimensional HTS data more
production of high-throughput screening is difficult tobiological significance, and can draw from the
cope with the large number of additional data, it isrelationship between morphological changes. High
not more than the needle in a haystack. This allowscontent drug screening Another important attraction
pharmaceutical companies to squeeze them in manyis its economy, especially in the current global financial
high-throughput screening program. For thecrisis, this is an important consideration. It can lower
pharmaceutical industry, possible alternative strategythe cost of traditional methods to obtain large
is to acquire permits and development of similaramounts of information. In addition, the high content
drugs, but the technical terms are likely to turn highdrug screening is also used in the discovery process
content screening (HCS).toxicological data early is crucial to help the
 development of the drug candidates have the
High-content drug screening is essentially a simplifiedproblem sorted and toxicity of compounds removed
method for drug discovery, but it is about a specificas soon as possible to reduce the subsequent
molecule with a specific receptor or enzymedemand for animal testing, due to high content drug
interactions can be very effective there. Forscreening is based on whole-cell research, so it can
example, receptors and enzymes can not exist ingenerate all animal experiments can only be provided
isolation, but they are complex cellular responses andby the data.
interaction part of the environment, high-content drug